Literature DB >> 24136389

Therapeutic plasma exchange in neuromyelitis optica: a case series.

Shanna M Morgan1, Nicole D Zantek, Adam F Carpenter.   

Abstract

Neuromyelitis optica (NMO) is a relapsing inflammatory disease of the central nervous system that predominantly affects the spinal cord and optic nerves. The clinical hallmark of the disease is a step-wise deterioration of visual and spinal cord function. This study reviews patients with steroid resistant relapsing NMO presenting for therapeutic plasma exchange (TPE) at our institution from December 2005 to December 2012. A total of five patients were treated with single volume TPE. Both subjective and objective clinical response to TPE was estimated by three different sources (the patient, a Transfusion Medicine physician, and the treating Neurologist) with the patient and Transfusion Medicine physician's final assessment of response made at the time of the last TPE in the series and the treating neurologist's assessment of response made at the time of the next neurological exam after the last TPE. A total of 17 TPE series were performed with the average course of therapy being three series (ranged 1-5) with five TPE (ranged 3-7) per series. All patients demonstrated improvement with each series of TPE and all procedures were well tolerated with only transient and well-described reactions all of which were successfully resolved with minor or no sequelae.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Devic's disease; apheresis; optic neuritis

Mesh:

Year:  2013        PMID: 24136389     DOI: 10.1002/jca.21304

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  7 in total

1.  Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response.

Authors:  Michael A Palacios-Mendoza; María L Martínez Ginés; Pedro J Melgarejo Otálora; Juan P Cuello; Antonio Sánchez-Soblechero; Alberto Lozano Ros; José A Aparcero-Suero; Sergio López Anguita; Fernando Anaya; José M García Domínguez
Journal:  Neurol Sci       Date:  2020-04-04       Impact factor: 3.307

2.  Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.

Authors:  Hesham Abboud; Alex Petrak; Maureen Mealy; Sarana Sasidharan; Laila Siddique; Michael Levy
Journal:  Mult Scler       Date:  2015-04-28       Impact factor: 6.312

3.  [Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding].

Authors:  F Hoffmann; A Kraft; F Heigl; E Mauch; J Koehler; L Harms; T Kümpfel; W Köhler; R Klingel; C Fassbender; S Schimrigk
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

Review 4.  Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials.

Authors:  Sean J Pittock; Anastasia Zekeridou; Brian G Weinshenker
Journal:  Nat Rev Neurol       Date:  2021-10-28       Impact factor: 42.937

5.  Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease.

Authors:  Ivana Nieto-Aristizábal; Álvaro J Vivas; Pablo Ruiz-Montaño; Cristian C Aragón; Iván Posso-Osorio; Jairo Quiñones; Julián Alejandro Rivillas; Gabriel J Tobón
Journal:  Autoimmune Dis       Date:  2020-07-31

6.  Therapeutic Efficacy of Plasma Exchange in Neuromyelitis Optica.

Authors:  Rajesh Kumar; Birinder Singh Paul; Gagandeep Singh; Amarjit Kaur
Journal:  Ann Indian Acad Neurol       Date:  2018 Apr-Jun       Impact factor: 1.383

7.  PLEX: the best first-line treatment in nmosd attacks experience at a single center in Colombia.

Authors:  C Restrepo-Aristizábal; L M Giraldo; Y M Giraldo; A M Pino-Pérez; F Álvarez-Gómez; C A Franco; J V Tobón; J L Ascencio; M I Zuluaga
Journal:  Heliyon       Date:  2021-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.